Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

5 clinical studies listed.

Filters:

Age Related Macular Degeneration (AMD)

Tundra lists 5 Age Related Macular Degeneration (AMD) clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ENROLLING BY INVITATION

NCT05481827

ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study

The purpose of this study is to evaluate the long-term safety of GT005 in participants with Geographic Atrophy (GA) secondary to AMD who have been treated in an antecedent study.

Gender: All

Ages: 55 Years - Any

Updated: 2026-09-28

16 states

Age Related Macular Degeneration (AMD)
COMPLETED

NCT07424235

Evaluating the Relationship Between Function and Structure Using Data From a GA Natural History Cohort

Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration that leads to progressive and irreversible vision loss. The course of visual decline varies widely among patients, and it is not always clear which anatomical features of the retina are associated with faster loss of vision. This retrospective observational study aims to describe the natural history of vision loss in patients with geographic atrophy who have characteristics similar to those enrolled in recent clinical trials. The study will analyze previously collected clinical and imaging data from patients followed during routine clinical care at a single center. The main goal of the study is to evaluate the relationship between changes in visual function and retinal anatomical features, such as the size and location of atrophic lesions and retinal layer integrity, using fundus autofluorescence and optical coherence tomography images. No treatments or study procedures are performed as part of this research. All data used in the study were collected during standard clinical practice and analyzed retrospectively.

Gender: All

Ages: 50 Years - Any

Updated: 2026-05-11

Age Related Macular Degeneration (AMD)
Age Related Macular Degeneration
AMD
+3
RECRUITING

NCT05932069

Active AMD Study to Improve Function in Veterans

Age Related Macular Degeneration (AMD) is the leading cause of vision loss among Veterans aged 50 years and older. AMD also adversely affects mortality, physical and cognitive functioning, and activities of daily living. These debilitations negatively impact quality of life for US Veterans. Unfortunately, there are no cures and few treatments. With the increase in the aging Veteran population and the increasing prevalence of AMD, it is imperative to identify and implement strategies to limit the functional burden of AMD. To address this growing challenge, the investigators propose to test the impact of a proven exercise intervention, stationary bicycling (spinning), on visual and non-visual negative health outcomes in AMD. The work in several retinal degeneration mouse models shows that aerobic exercise significantly preserves retinal morphology and function and visual acuity. Even more exciting, the investigators' preliminary work with older Veterans with and without AMD suggests that spin cycling modestly but significantly benefits visual acuity in aged Veterans. Based on this work, the investigators propose to implement a 6-month synchronous, online group spin cycling program for Veterans with AMD, evaluating effects on physical, cognitive, and visual outcomes.

Gender: All

Ages: 65 Years - 89 Years

Updated: 2026-02-23

1 state

Age Related Macular Degeneration (AMD)
NOT YET RECRUITING

NCT06908161

Functional Assessments in Vision Impairment

The aim of the research project is to validate the use of a novel functional assessment tool designed to document how participants with a vision impairment complete activities of daily living in a real world environment.

Gender: All

Ages: 18 Years - Any

Updated: 2025-04-03

1 state

Retinitis Pigmentosa (RP)
Diabetic Retinopathy (DR)
Age Related Macular Degeneration (AMD)
+2
ACTIVE NOT RECRUITING

NCT03349801

Development of Novel Clinical Endpoints in Intermediate AMD

Development of novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention in patients with intermediate age-related macular degeneration (AMD) - MACUSTAR

Gender: All

Ages: 55 Years - 85 Years

Updated: 2025-01-16

Age Related Macular Degeneration (AMD)